Category - Pharma Industry News
Alnylam and PTC Therapeutics’ rare disease drugs given backing by NICE
Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
January 19 2023 – Sun Pharma to purchase Concert Pharmaceuticals for $576M
Genentech announce positive results from phase 3 IMbrave050 study
Abbott secures FDA approval for Navitor TAVI device
Moderna’s mRNA vaccine appears promising for older adults with RSV
Johnson & Johnson cuts trial for its HIV vaccine following disappointing data
NICE recommends AMVUTTRA®▼ (vutrisiran) as treatment for a hereditary form of amyloidosis in draft guidance